Myeloproliferative Neoplasms News

Healio.com/HemOnc has launched In the Journals Plus, a new feature that will provide busy physicians with summaries of the top articles from leading journals in hematology and oncology.

Repeated infusions of mesenchymal stromal cells reduced the incidence of chronic graft-versus-host disease in patients who underwent haploidentical hematopoietic stem cell transplantation, according to results of a double blind randomized controlled phase 2 study.

Cytomegalovirus infection conferred no protective effect against hematologic relapse in patients with leukemia who underwent hematopoietic stem cell transplantation, according to the results of an international registry study.

Life-preserving treatments once frequently threatened the fertility of patients with cancer.

Progress has been made across the United States to pass and implement legislative solutions to prevent and fight cancer, according to an American Cancer Society Cancer Action Network report.

Patients who underwent hematopoietic stem cell transplantation with bone marrow from unrelated donors reported better 5-year outcomes than those who received peripheral blood, according to long-term follow-up data from a randomized trial.

The oral multikinase inhibitor midostaurin exhibited efficacy in patients with advanced systemic mastocytosis, according to the results of an open-label, multicenter phase 2 study.

Adult umbilical cord blood transplantation produced lower rates of chronic graft-versus-host disease than peripheral blood transplants from matched, unrelated donors, according to a single institution study.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

The use of a double unit of unrelated cord blood did not significantly decrease transplantation failure in children and young adults with acute leukemia or myelodysplastic syndrome compared with using a single unit with adequate cell dose, according to the results of a randomized trial.